Congressional Republicans and Democrats joined forces on Thursday to pass the 21st Century Cures Act, a comprehensive piece of healthcare legislation that provides funding for researching some of America’s biggest health concerns.

Senate Vote 94–5

The legislation passed a Senate vote 94–5, with opposition from only a handful of Democrats, including Sen. Elizabeth Warren and former presidential candidate Sen. Bernie Sanders. Warren expressed concerns with how much the legislation would benefit pharmaceutical companies.

Details

In fact, the 21st Century Cures Act stands to benefit people with mental illnesses, patients with chronic diseases, pregnant women, children with diabetes, people with opioid addictions, children who are bullied and people who are terminally ill. And of course, it will also benefit hospitals and biomedical researchers.

Shares of Egalet Corp EGLT 5.66% jumped 5.5 percent Thursday on market speculation that the 21st Century Cures Act could have a meaningful impact on companies developing products incorporating opioid abuse deterrents.

Click to play video.

The act includes $4.8 billion of National Institute of Health (NIH) funding for four “innovative projects,” including cancer research, brain research, the Precision Medicine Initiative (PMI) and regenerative medicine.

Commentary

According to Wells Fargo analyst Tim Evans, biotech investors shouldn’t expect a major impact from the funds, although large tools companies Illumina, Inc. ILMN 0.23% and Thermo Fisher Scientific Inc. TMO 1.64% will likely get a combined 5 percent of the annual NIH budget.

“Applying that same percentage to the incremental funding would result…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!